The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC
Open accessAbstract
Background and Aims: Type 3 innate lymphoid cells (ILC3s) are essential for host defense against infection and tissue homeostasis. However, their role in the development of HCC has not been adequately confirmed. In this study, we investigated the immunomodulatory role of short‐chain fatty acids (SCFAs) derived from intestinal microbiota in ILC3 regulation. Approach and Results: We report that Lactobacillus reuteri was markedly reduced in the gut microbiota of mice with HCC, accompanied by decreased SCFA levels, especially acetate. Additionally, transplantation of fecal bacteria from wild‐type mice or L. reuteri could promote an anticancer effect, elevate acetate levels, and reduce IL‐17A secretion in mice with HCC. Mechanistically, acetate reduced the production of IL‐17A in hepatic ILC3s by inhibiting histone deacetylase activity, increasing the acetylation of SRY (sex‐determining region Y)‐box transcription factor 13 (Sox13) at site K30, and decreasing expression of Sox13. Moreover, the combination of acetate with programmed death 1/programmed death ligand 1 blockade significantly enhanced antitumor immunity. Consistently, tumor‐infiltrating ILC3s correlated with negative prognosis in patients with HCC, which could be functionally mediated by acetate. Conclusions: These findings suggested that modifying bacteria, changing SCFAs, reducing IL‐17A‐producing ILC3 infiltration, and combining with immune checkpoint inhibitors will contribute to the clinical treatment of HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812 · cited 1×
“Studies in recent years have shown that the outcome of cancer immunotherapy can be enhanced by the influence of the gut microbiome and its metabolite on the immune system.[33] Compared with germ‐free mice or mice with interfering microbiota, mice with healthy gut microbiota usually respond more favorably to anti‐PD‐1…”
BackgroundCommensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · cited 1×
“[33] Compared with germ‐free mice or mice with interfering microbiota, mice with healthy gut microbiota usually respond more favorably to anti‐PD‐1 treatment.[34]] In this study, we further corroborated these observations that ILC3 cells in liver cancer can also express immune checkpoint molecules, which may result in…”
ResultGut microbiota, metabolites and host immunity
Rooks, M. G., & Garrett, W. S. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.42 · Cited by 3,409
The immunology of hepatocellular carcinoma
Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E., & Heikenwalder, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0044-z · Cited by 1,076
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
Kirchberger, S., Royston, D. J., Boulard, O., Thornton, E., Franchini, F., Szabady, R. L., Harrison, O., & Powrie, F. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122308 · Cited by 529
Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity
Chun, E., Lavoie, S., Fonseca-Pereira, D., Bae, S., Michaud, M., Hoveyda, H. R., Fraser, G. L., Gallini Comeau, C. A., Glickman, J. N., Fuller, M. H., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.09.014 · Cited by 336
Targeting the interleukin-17 immune axis for cancer immunotherapy
Vitiello, G. A., & Miller, G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190456 · Cited by 151
Experimental Evaluation of Host Adaptation of Lactobacillus reuteri to Different Vertebrate Species
Duar, R. M., Frese, S. A., Lin, X. B., Fernando, S. C., Burkey, T. E., Tasseva, G., Peterson, D. A., Blom, J., Wenzel, C. Q., Szymanski, C. M., et al. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.00132-17 · Cited by 104
Cited by
Ney, L.-M., Wipplinger, M., Grossmann, M., Engert, N., Wegner, V. D., & Mosig, A. S. (2023) · Open Biology · doi:10.1098/rsob.230014 · Cited by 315
Song, Q., Zhang, X., Liu, W., Wei, H., Liang, W., Zhou, Y., Ding, Y., Ji, F., Ho-Kwan Cheung, A., Wong, N., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.07.005 · Cited by 293
Metabolic reprogramming in the tumor microenvironment of liver cancer
Lin, J., Rao, D., Zhang, M., & Gao, Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01527-8 · Cited by 251
“Thus, combining acetate supplementation with PD-1 blockades significantly boosts anti-tumor immunity [227].”
BackgroundDong, Y., Zhang, K., Wei, J., Ding, Y., Wang, X., Hou, H., Wu, J., Liu, T., Wang, B., & Cao, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1158200 · Cited by 107
“The 16s RNA expression of butyrate-producing bacteria in HCC patients decreased, and butyrate supplementation could promote apoptosis and inhibit proliferation in HepG2 cells.”
BackgroundInfluentialSelf-citationLimosilactobacillus reuteri - a probiotic gut commensal with contextual impact on immunity
Lee, A. H., Rodriguez Jimenez, D. M., & Meisel, M. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2451088 · Cited by 66
Metadata
- Authors
- Hu, C., Xu, B., Wang, X., Wan, W., Lu, J., Kong, D., Jin, Y., You, W., Sun, H., Mu, X., Feng, D., & Chen, Y.
- Venue
- Hepatology
- Published
- 2022-03-21
- Volume
- 77
- Issue
- 1
- Pages
- 48-64
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W4220897697
- Cited by
- 199
- References
- 10
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC. https://app.cochat.ai/papers/10.1002/hep.32449
- The paper
- Hu, C., Xu, B., Wang, X., Wan, W., Lu, J., Kong, D., Jin, Y., You, W., Sun, H., Mu, X., Feng, D., & Chen, Y. (2023). Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC. Hepatology. https://doi.org/10.1002/hep.32449
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.